Investing Profile
Greg Yap
Your Intro Paths to Greg Yap
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Greg is a member of
GE Network
108 CONNECTIONS
The Aspen Institute Network
63 CONNECTIONS
Menlo Ventures Network
48 CONNECTIONS
H1 Network
13 CONNECTIONS
Find Greg Yap on
cbCurrent Investing Position
Menlo Ventures Partner
Investment Range
$8.0M - $15.0M
Sweet Spot
$12.0M
Investments On Record
37
Current Fund Size
$500M
Greg Yap is on these Sector & Stage Rankings
Medical Devices (Seed)BioTech (Series B)Medical Devices (Series B)Medical Devices (Series A)BioTech (Seed)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)San Francisco Bay AreaDigital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)
Greg Yap's Investments On Record (21)
Sign in to see all 21 investments on record.
Sign in with Google →Greg Yap's Experience
Investor Xaira Therapeutics2024 - Present
Board Member & Investor Vilya2023 - Present
Board Member & Investor Cartwheel2023 - Present
Board Member & Investor Koala Health2022 - Present
Investor Scribe Therapeutics2021 - Present
Board Member & Investor Ophelia2021 - Present
Board Member & Investor Particle Health2020 - Present
Board Member & Investor H12020 - Present
Board Observer & Investor Genesis Therapeutics2020 - Present
Health Innovators Fellow The Aspen Institute2019 - Present
Board Member & Investor Clear Labs2019 - Present
Investor Benchling2019 - Present
Investor Encoded Therapeutics Inc.2019 - Present
Board Member & Investor Riva Health2019 - Present
Board Member & Investor Delfi Diagnostics2019 - Present
Board Member & Investor Epiodyne2018 - Present
Investor Pliant Therapeutics2018 - Present
Partner Menlo Ventures2017 - Present
Investor Recursion2017 - Present
Board Member Outward Bound California2013 - Present
Entrepreneur in Residence Illumina Ventures2016 - 2017
CEO & Co-founder PyrAmes2016 - 2017
CEO & Co-founder Biodesy (now BlueLight Therapeutics, Inc.)2013 - 2016
Entrepreneur in Residence GE2013 - 2013
Lifecycle Leader (SVP), Advanced Assays Ventana Medical Systems2010 - 2013
Lifecycle Leader (SVP), Advanced Assays Roche Diagnostics2010 - 2013
Chief Operating Officer CellPoint Diagnostics2008 - 2009
Vice President, Molecular Diagnostics Affymetrix2006 - 2008
Vice President, DNA Products Affymetrix2001 - 2005
Director, Business Development Affymetrix1997 - 1999
Business Analyst McKinsey1995 - 1997
Investors who invest with Greg Yap
Sign in with Google →Scouts & Angels Affiliated With Greg Yap
Sign in with Google →